NEFL and type 1 diabetes mellitus: Finally, we assessed plasma neurofilament light chain (NfL) levels, a recognised biomarker for neurodegeneration [11] associated to neuronal loss and axonal damage, finding higher levels in patients with T1D‐IAH, which correlated to reduced cerebral GM volume and IAH severity [10].